{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:18:31Z","timestamp":1775114311241,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/bmt.2008.389","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T11:47:39Z","timestamp":1228132059000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report"],"prefix":"10.1038","volume":"43","author":[{"given":"M D","family":"Aljurf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Z","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"El Solh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H K","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T Ben","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M M","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Benchekroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Labar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gratwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,1]]},"reference":[{"key":"BFbmt2008389_CR1","unstructured":"Countries in the WHO Eastern Mediterranean Region shown on http:\/\/www.who.int\/about\/regions\/emro\/en\/index.html (last accessed on 12th September 2008)."},{"key":"BFbmt2008389_CR2","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1038\/bmt.2008.137","volume":"42","author":"T Shamsi","year":"2008","unstructured":"Shamsi T, Hashmi K, Irfan M, Ahmed P, Farzana T, Satti T et al. The stem cell transplant program in pakistan\u2014the first decade. Bone Marrow Transplant 2008; 42: S114\u2013S117.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR3","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1038\/bmt.2008.143","volume":"42","author":"TB Othman","year":"2008","unstructured":"Othman TB, Torjemane L, Abdelkefi A, Lakhal A, Ladeb S, Hamed LB et al. Allogeneic stem cell transplantation in Tunisia. Bone Marrow Transplant 2008; 42: S139\u2013S141.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR4","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1038\/bmt.2008.136","volume":"42","author":"HK Mahmoud","year":"2008","unstructured":"Mahmoud HK, El-Haddad AM, Fahmy OA, El-Emary M, Nassar A, Abdel-Mooti M et al. Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant 2008; 42: S76\u2013S80.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR5","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1038\/bmt.2008.126","volume":"42","author":"F Abdel-Rahman","year":"2008","unstructured":"Abdel-Rahman F, Hussein AA, Rihani R, Hlalah OA, El Taani H, Sharma S et al. Bone marrow and stem cell transplantation at King Hussein Cancer Center (KHCC) Amman\u2014Jordan. Bone Marrow Transplant 2008; 42: S89\u2013S91.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR6","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1038\/bmt.2008.131","volume":"42","author":"D Dennison","year":"2008","unstructured":"Dennison D, Al Kindi S, Pathare A, Daar S, Nusrat N, Rehman J et al. Hematopoietic stem cell transplantation in Oman. Bone Marrow Transplant 2008; 42: S109\u2013S113.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR7","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/bmt.2008.128","volume":"42","author":"A Bazarbachi","year":"2008","unstructured":"Bazarbachi A, Hatoum HA, Mugharbel A, Otrock ZK, Yassine N, Muwakkit S et al. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant 2008; 42: S96\u2013S102.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR8","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1038\/bmt.2008.130","volume":"42","author":"S Benchekroun","year":"2008","unstructured":"Benchekroun S, Harif M, Madani A, Quessar A, Zafad S, Rachid R . Present and future of hematology and stem cell transplantation in Morocco. Bone Marrow Transplant 2008; 42: S106\u2013S108.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2008389_CR9","first-page":"265b","volume":"88","author":"KV Sheth","year":"1996","unstructured":"Sheth KV, Elkhalifa M, Kelly T, Sahovic E . What are the chances of finding related HLA match donors for allogeneic BMT recipients in Saudi Arabia? Blood 1996; 88 (Suppl 1): 265b (Abstract 3787).","journal-title":"Blood"},{"issue":"Suppl 2","key":"BFbmt2008389_CR10","first-page":"677","volume":"29","author":"M Gyger","year":"2002","unstructured":"Gyger M, Sahovic E, Al Mohareb F, Chaudhri N, Al Zahrani H, Al Sharif F et al. A prospective randomized trial of marrow versus mobilized peripheral blood in HLA-matched related allogeneic transplants using a three-day short course methotrexate and cyclosporin as prophylaxis for acute graft versus host disease. Bone Marrow Transplant 2002; 29 (Suppl 2): 677 (abstract 84).","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 2","key":"BFbmt2008389_CR11","first-page":"S135","volume":"35","author":"A Al Beihany","year":"2005","unstructured":"Al Beihany A, Sahovic E, Chaudhri N, Almohareb F, Alsharif F, Alzahrani H et al. Leukemia relapse after allogeneic bone marrow transplantation\u2014how does chronic GVHD influence the pattern and onset of relapse? Bone Marrow Transplant 2005; 35 (Suppl. 2): S135 (Abstract 536).","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.bmt.1705488","volume":"38","author":"Stem Cell Trialists' Collaborative Group","year":"2006","unstructured":"Stem Cell Trialists' Collaborative Group. Individual patient data met-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration. Bone Marrow Transplant 2006; 38: 539\u2013546.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR13","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","volume":"23","author":"Stem Cell Trialists' Collaborative Group","year":"2005","unstructured":"Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient care data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074\u20135087.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008389_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2004-06-2385","volume":"105","author":"H Oh","year":"2005","unstructured":"Oh H, Loberiza Jr FR, Zhang MJ, Ringd\u00e9n O, Akiyama H, Asai T et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic population. Blood 2005; 105: 1408\u20131416.","journal-title":"Blood"},{"key":"BFbmt2008389_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.tpj.6500251","volume":"4","author":"R Bu","year":"2004","unstructured":"Bu R, Gutierrez MI, Al-Rasheed M, Belgaumi A, Bhatia K . Variable drug metabolism genes in Arab population. Pharmacogenomics J 2004; 4: 260\u2013266.","journal-title":"Pharmacogenomics J"},{"key":"BFbmt2008389_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1056\/NEJM199704103361504","volume":"336","author":"KE Brown","year":"1997","unstructured":"Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS . Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336: 1059\u20131064.","journal-title":"N Engl J Med"},{"key":"BFbmt2008389_CR17","doi-asserted-by":"publisher","first-page":"2051\u2212","DOI":"10.1001\/jama.1992.03480150057037","volume":"267","author":"JR Hibbs","year":"1992","unstructured":"Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A et al. Aplastic anemia and viral hepatitis non-A, non-B, non-C? JAMA 1992; 267: 2051\u2212\u20132054.","journal-title":"JAMA"},{"key":"BFbmt2008389_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BFbmt2008389_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00277-004-0923-2","volume":"83","author":"KW Lee","year":"2004","unstructured":"Lee KW, Choi IS, Roh EY, Kim DY, Yun T, Lee DS et al. Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience. Ann Hematol 2004; 83: 218\u2013224.","journal-title":"Ann Hematol"},{"key":"BFbmt2008389_CR20","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","volume":"23","author":"G Marcucci","year":"2005","unstructured":"Marcucci G, Maharry K, Radmacher MD, Mr\u00f3zek K, Vukosavljevic T, Paschka P et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol 2005; 23: 5705\u20135717.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008389_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V86.1.1.bloodjournal8611","volume":"86","author":"G Nucifora","year":"1995","unstructured":"Nucifora G, Rowley JD . AMLl and the 8;21 and 3;21 Translocations in Acute and Chronic Myeloid Leukemia. Blood 1995; 86: 1\u201314.","journal-title":"Blood"},{"key":"BFbmt2008389_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","volume":"84","author":"AMS Muller","year":"2005","unstructured":"Muller AMS, Ihorst G, Mertelsmann R, Engelhardt M . Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1\u201312.","journal-title":"Ann Hematol"},{"key":"BFbmt2008389_CR23","first-page":"372b","volume":"94","author":"E Sahovic","year":"1999","unstructured":"Sahovic E, Al-Suliman A, Aslam M, Seth P, Akhtar J, Aljurf M et al. Successful prevention of CMV disease after allogeneic BMT in 100 consecutive CMV seropositive recipients. Blood 1999; 94: 372b (Abstract 4888).","journal-title":"Blood"},{"key":"BFbmt2008389_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.bmt.1702869","volume":"27","author":"M Chandy","year":"2001","unstructured":"Chandy M, Srivastava A, Dennison D, Mathews V, George B . Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplant 2001; 27: 785\u2013790.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V93.5.1781","volume":"93","author":"M Boeckh","year":"1999","unstructured":"Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L . Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 1999; 93: 1781.","journal-title":"Blood"},{"key":"BFbmt2008389_CR26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5144\/0256-4947.1988.474","volume":"8","author":"FZ Al-Faleh","year":"1988","unstructured":"Al-Faleh FZ . Hepatitis B infection in Saudi Arabia. Ann Saudi Med 1988; 8: 474\u2013480.","journal-title":"Ann Saudi Med"},{"key":"BFbmt2008389_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jmv.1890170308","volume":"17","author":"SC Arya","year":"1985","unstructured":"Arya SC, Ashraf SJ, Parande CM, el-Sayed M, Sahay R, Ageel AR et al. Hepatitis B virus in Gizan. Saudi Arabia. J Med Virol 1985; 17: 267\u2013274.","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"BFbmt2008389_CR28","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0264-410X(99)00456-9","volume":"18","author":"F Andre","year":"2000","unstructured":"Andre F . Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 (Suppl 1): S20\u2013S22.","journal-title":"Vaccine"},{"key":"BFbmt2008389_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1703614","volume":"30","author":"P Seth","year":"2002","unstructured":"Seth P, Alrajhi AA, Kagevi I, Chaudhary MA, Colcol E, Sahovic EA et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 30: 189\u2013194.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR30","first-page":"41","volume":"3","author":"SY Theodore","year":"2006","unstructured":"Theodore SY, Jamal MM . Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 41\u201346.","journal-title":"Int J Med Sci"},{"key":"BFbmt2008389_CR31","first-page":"359","volume":"33","author":"AA Saeed","year":"1991","unstructured":"Saeed AA, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R, Ring C et al. Hepatitis C virus in Egyptian blood donors in Riyadh. Lancet 1991; 33: 359\u2013360.","journal-title":"Lancet"},{"key":"BFbmt2008389_CR32","first-page":"26","volume":"25","author":"MM El-Hazmi","year":"2004","unstructured":"El-Hazmi MM . Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I\/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 2004; 25: 26\u201333.","journal-title":"Saudi Med J"},{"key":"BFbmt2008389_CR33","first-page":"69","volume":"74","author":"H Mahaba","year":"1999","unstructured":"Mahaba H, el-Tayeb Ael-K, Elbaz H . The prevalence of antibodies to hepatitis C virus in Hail region, Saudi Arabia. J Egypt Public Health Assoc 1999; 74: 69\u201380.","journal-title":"J Egypt Public Health Assoc"},{"key":"BFbmt2008389_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jmv.1890400413","volume":"40","author":"AM El Guneid","year":"1993","unstructured":"El Guneid AM, Gunaid AA, O\u2032Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM . Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993; 40: 330\u2013333.","journal-title":"J Med Virol"},{"key":"BFbmt2008389_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5144\/0256-4947.1997.601","volume":"17","author":"MN Al-Ahdal","year":"1997","unstructured":"Al-Ahdal MN, Rezeig MA, Kessie G . Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from pcr-amplified core region of the virus genome. Ann Saudi Med 1997; 17: 601\u2013604.","journal-title":"Ann Saudi Med"},{"key":"BFbmt2008389_CR36","first-page":"7","volume":"23","author":"AO Osoba","year":"2002","unstructured":"Osoba AO . Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J 2002; 23: 7\u201312.","journal-title":"Saudi Med J"},{"key":"BFbmt2008389_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1099\/0022-1317-51-8-700","volume":"51","author":"S Bdour","year":"2002","unstructured":"Bdour S . Hepatitis C virus infection in Jordanian haemodialyis units, serological diagnosis and genotyping. J Med Microbiol 2002; 51: 700\u2013704.","journal-title":"J Med Microbiol"},{"key":"BFbmt2008389_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1096-9071(199905)58:1<44::AID-JMV6>3.0.CO;2-U","volume":"58","author":"OA Shobokshi","year":"1999","unstructured":"Shobokshi OA, Serebour FE, Skakni L, Al Safy YH, Ahdal MN . Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 1999; 58: 44\u201348.","journal-title":"J Med Virol"},{"key":"BFbmt2008389_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-5926-5-4","volume":"5","author":"A Kabir","year":"2006","unstructured":"Kabir A, Alavian S, Keyvani H . Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006; 5: 4; doi:10.1186\/1476-5926-5-4.","journal-title":"Comp Hepatol"},{"key":"BFbmt2008389_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bmt.1701930","volume":"24","author":"M Aljurf","year":"1999","unstructured":"Aljurf M, Gyger M, Alrajhi A, Sahovic E, Chaudhri N, Musa M et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551\u2013554.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR41","first-page":"659","volume":"6","author":"Centers for Disease Control and Prevention; Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation","year":"2000","unstructured":"Centers for Disease Control and Prevention; Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients; recommendations of the CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2000; 6: 659\u2013734.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008389_CR42","first-page":"401","volume":"17","author":"HK Mahmoud","year":"1996","unstructured":"Mahmoud HK . Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 401\u2013403.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR43","unstructured":"Roll Back Malaria Monitoring and Evaluation in Pakistan\u2013 WHO report http:\/\/www.rbm.who.int\/wmr2005\/profiles\/paquistan.pdf."},{"key":"BFbmt2008389_CR44","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood-2002-03-0675","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A . Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374\u20132386.","journal-title":"Blood"},{"key":"BFbmt2008389_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.bmt.1705377","volume":"37","author":"A Gratwohl","year":"2006","unstructured":"Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Joint Accreditation Committee, International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006; 37: 1069\u20131085.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR46","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/bmt.2008.104","volume":"42","author":"A Gratwohl","year":"2008","unstructured":"Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D . Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant 2008; 42: S7\u2013S10.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008389_CR47","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3324\/haematol.11260","volume":"92","author":"A Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D et al. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679\u20131686.","journal-title":"Haematologica"},{"key":"BFbmt2008389_CR48","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.leu.2402896","volume":"17","author":"A Gratwohl","year":"2003","unstructured":"Gratwohl A, Baldomero H, Passweg J, Frassoni F, Niederwieser D, Schmitz N et al., for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) in cooperation with the Working Parties Acute (ALWP) and Chronic Leukemias (CLWP) and the Lymphoma Working Party Hematopoietic stem cell transplantation for hematological malignancies in Europe. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 2003; 17: 941\u2013959.","journal-title":"Leukemia"},{"key":"BFbmt2008389_CR49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A, for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of hematopoietic stem cell transplants in Europe. Br J Haemtol 2002; 117: 451\u2013468.","journal-title":"Br J Haemtol"},{"key":"BFbmt2008389_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.leu.2404509","volume":"21","author":"A Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Urbano-Ispizua A, Frauendorfer K . Haematopoietic stem cell transplants for chronic myeloid leukemia in Europe. Impact of cost considerations. Leukemia 2007; 21: 383\u2013386.","journal-title":"Leukemia"},{"key":"BFbmt2008389_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.leu.2404534","volume":"3","author":"JL Gajewski","year":"2007","unstructured":"Gajewski JL . Do affluent societies have the only options for the best therapy. Leukemia 2007; 3: 387\u2013388.","journal-title":"Leukemia"},{"key":"BFbmt2008389_CR52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1365-2141.2003.04793.x","volume":"124","author":"NH Russell","year":"2004","unstructured":"Russell NH, Szydlo R, McCann S, Potter MN, Craddock C, Towlson K et al. British Society for Blood and Marrow Transplantation. The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland. Br J Haematol 2004; 124: 499\u2013503.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008389","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:11:46Z","timestamp":1648033906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFbmt2008389"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.389","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,1]]},"assertion":[{"value":"15 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}